| Executive Management |
|
|
|
Lars Kongsbak joined Exiqon in 2000 as head of the EURAY division, later of R&D and finally was in charge of Business Development, before he was appointed as CEO in 2003. Before joining Exiqon, Lars Kongsbak served as Senior Scientist with Novozymes, Novo Nordisk and Bioimage, respectively. For several years, Lars Kongsbak was a Post Doc in the United States, Australia and Denmark. Lars Kongsbak is the inventor of several patents and the author of more than 40 scientific publications. Lars earned his M.Sc. in Biology from the University of Copenhagen (1988) and his Ph.D. in Molecular Biology from the Technical University of Denmark (1990).
|
|
|
Hans Henrik Chrois Christensen joined Exiqon as CFO in January 2007 from a corresponding position with Pharmexa A/S. Hans Henrik Chrois Christensen has a background as a group general counsel with Danisco A/S (1998-2002) where he completed an in-house management training programme, and as an attorney at-law with the law firm Dragsted & Helmer Nielsen (now Bech-Bruun), Copenhagen. Hans Henrik earned his Master of Laws from the University of Copenhagen (1990) and became an authorized attorney-at-law in 1993 with a right to appear before the Danish High Court.
|
|
|
Cynthia K. French joined Exiqon in July of 2008 from Affymetrix, where she served as Vice President, Clinical Services Laboratory, responsible for building and operating the CLIA laboratory. Prior to Affymetrix, Cynthia served as Vice President, Chief Scientific Officer at Speciality Laboratories and before then she held a number of senior positions at Quest Diagnostics Inc., Pluvita, Bio-Rad Laboratories, Diagnostic Products Corporation and Du Pont. Cynthia was the co-founder of Pluvita and she was responsible for the merger of the company with Diogenics. Cynthia received her Ph.D. and MBA from the University of California and she was a postdoctoral fellow at MIT and Harvard University.
|
| |
|
Mark Willig joined Exiqon in November 2009 from Thermo Fisher Scientific, Inc. where he held a position as Vice President of Global Sales since 2007 serving customers within the pharmaceutical and biotech industry, hospitals, clinical laboratories, research institutions and government agencies. Prior to Thermo Fisher Scientific, Inc., Mark has served in various senior management positions at Prognostix, Inc., Specialty Labs, Inc., Myriad Genetics, Inc. and Orca Medical Systems, Inc. Mark holds a BS in Speech Communication and Minor in History from the University of Missouri.
| |
|
| * Registered with the Danish Commerce and Companies Agency | |
|
|
|
|
|